Cardiol Therapeutics (CRDL) Current Assets: 2021
Historic Current Assets for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $69.5 million.
- Cardiol Therapeutics' Current Assets rose 111.37% to $52.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $52.0 million, marking a year-over-year increase of 111.37%. This contributed to the annual value of $69.5 million for FY2021, which is N/A change from last year.
- Latest data reveals that Cardiol Therapeutics reported Current Assets of $69.5 million as of FY2021.
- In the past 5 years, Cardiol Therapeutics' Current Assets registered a high of $69.5 million during FY2021, and its lowest value of $69.5 million during FY2021.
- Over the past 1 years, Cardiol Therapeutics' median Current Assets value was $69.5 million (recorded in 2021), while the average stood at $69.5 million.